Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Anthropic
Biotech
Anthropic director Vas Narasimhan bets AI can speed Novartis R&D
Novartis CEO and Anthropic board director Vas Narasimhan suggests that improving drug R&D success rate will be a “10-year-plus journey” for AI.
Angus Liu
Nov 19, 2026 5:31pm
Generate sees ‘huge opportunity’ using Claude to improve CAR-Ts
Nov 6, 2026 10:02am
Anthropic details drug R&D ambitions, risks in IPO filing
Oct 26, 2026 2:00pm
Icon inks Anthropic deal to deploy Claude into clinical trials
Aug 4, 2026 4:20pm
Fierce Pharma
BMS taps Anthropic’s Claude for enterprise-wide AI adoption
May 20, 2026 10:16am
Fierce Pharma
Novartis CEO Vas Narasimhan joins Anthropic's board
Apr 15, 2026 10:36am